These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 147562)

  • 1. Lack of evidence of chalone activity in used medium and extract of JB-1 tumor cells in vitro. A flow cytometry study.
    Naeser FK; Barfod NM; Bichel P
    Virchows Arch B Cell Pathol; 1978 Feb; 26(4):321-9. PubMed ID: 147562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Employment of synchronized cells and flow microfluorometry in investigations on the JB-1 ascites tumour chalones.
    Bichel P; Barfod NM; Jakobsen A
    Virchows Arch B Cell Pathol; 1975 Nov; 19(2):127-33. PubMed ID: 127415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific chalone inhibition of the regeneration of the JB-1 ascites tumour studied by flow microfluorometry.
    Bichel P; Barfod NM
    Cell Tissue Kinet; 1977 Mar; 10(2):183-93. PubMed ID: 140007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a G1 inhibitor from old JB-1 ascites tumor fluid. Interaction with polyions and ion exchangers.
    Barfod NM; Bichel P
    Virchows Arch B Cell Pathol; 1976 Sep; 21(3):249-58. PubMed ID: 823703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural and functional significance of association of a low molecular weight chalone from JB-1 ascites tumours with high molecular weight factors.
    Barfod NM; Schjerbeck P
    Cell Tissue Kinet; 1982 Jul; 15(4):457-68. PubMed ID: 6213306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A flow cytometric in vivo chalone assay using retransplanted old murine JB-1 ascites tumour cells.
    Barfod NM
    Cell Tissue Kinet; 1981 Jul; 14(4):389-94. PubMed ID: 6455199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and partial identification of eight endogenous G1 inhibitors of JB-1 ascites tumor cell proliferation.
    Barfod NM
    Cancer Res; 1982 Jun; 42(6):2420-5. PubMed ID: 7074619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow microfluorometric estimation of G1 and G2 chalone inhibition of the JB-1 tumour cell cycle in vitro.
    Barfod NM
    Exp Cell Res; 1977 Nov; 110(1):225-36. PubMed ID: 144604
    [No Abstract]   [Full Text] [Related]  

  • 9. Further studies on the self-limitation of growth of JB-1 ascites tumours.
    Bichel P
    Eur J Cancer (1965); 1973 Feb; 9(2):133-8. PubMed ID: 4717486
    [No Abstract]   [Full Text] [Related]  

  • 10. Chalone-like inhibition of Ehrlich ascites cell proliferation in vitro by an ultrafiltrate obtained from the ascitic fluid.
    Lehmann W; Graetz H; Schütt M; Langen P
    Acta Biol Med Ger; 1977; 36(7-8):K 43-52. PubMed ID: 148196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On a "chalone"-like factor for Ehrlich ascites mammary carcinoma.
    Lehmann W; Graetz H; Samtleben R; Schütt M; Langen P
    Acta Biol Med Ger; 1980; 39(1):93-105. PubMed ID: 6448529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell cycle specificity and reversibility of the inhibitory effect of epidermal G1-chalone on DNA synthesis in partially synchronized RTE-2 keratinocytes in vitro.
    Tiegel A; Richter KH; Marks F
    Exp Cell Res; 1989 Jun; 182(2):297-306. PubMed ID: 2524400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversible G2 block in the cell cycle of Ehrlich ascites carcinoma cells.
    Lazebnik YA; Medvedeva ND; Zenin VV
    Exp Cell Res; 1991 Jul; 195(1):247-54. PubMed ID: 2055271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ARH-77, an established human IgG-producing myeloma cell line. II. Growth kinetics, clonogenic capacity, chalone production, xenogeneic transplantations, and response to melphalan.
    Drewinko B; Mars W; Stragand JJ; Henderson SD; Latreille J; Barlogie B; Trujillo JM
    Cancer; 1984 Nov; 54(9):1893-903. PubMed ID: 6236873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for granulopoiesis inhibitors (chalones) by different assays.
    Maschler R; Maurer HR
    Hoppe Seylers Z Physiol Chem; 1978 Jul; 359(7):825-34. PubMed ID: 150389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental plasmacytoma in mice. II. Qualitative studies of myeloma proteins.
    Salwa J
    Arch Immunol Ther Exp (Warsz); 1981; 29(1):131-6. PubMed ID: 7283675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell proliferation kinetics of epidermis and sebaceous glands in relation to chalone action.
    Laurence EB; Spargo DJ; Thornley AL
    Cell Tissue Kinet; 1979 Nov; 12(6):615-33. PubMed ID: 159773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An inhibitor of DNA-synthesis, isolated from rat tumor-induced ascites.
    Wallevik K; Jensenius JC; Larsen JK; Krøll J; Lassota H
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1982; 39(2):145-58. PubMed ID: 6123188
    [No Abstract]   [Full Text] [Related]  

  • 19. A system for the study of epidermal G1-chalone in cell culture. The rat tongue epithelial cell line RTE2.
    Richter KH; Jepsen A; Marks F
    Exp Cell Res; 1984 Jan; 150(1):68-76. PubMed ID: 6229413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal G1-chalone and transforming growth factor-beta are two different endogenous inhibitors of epidermal cell proliferation.
    Richter KH; Schnapke R; Clauss M; Fürstenberger G; Hinz D; Marks F
    J Cell Physiol; 1990 Mar; 142(3):496-504. PubMed ID: 1968903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.